5-amino-1mq nnmt inhibitor study obesity Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger than placebo at 52 weeks 5-Amino-1MQ - Pure Health Size:5mg*10vials Nicotinamide N-Methyltransferase Inhibitor
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18